IQVIA 2018 APAC Healthcare Summit
October 11, 2018
10:00AM - 6:00PM
View map

The promise of Big Data in healthcare is tantalizing, and its pace of growth is staggering. Companies applying data-driven decisions are seeing increased productivity and profitability compared to competitors. There is no denying that in today’s world, Data is King and the ability to make sense of the data and extracting value from it, makes you a leader. 

We are witnessing a new age of business backed by data science applications in every industry, including healthcare. But dealing with human data poses unique challenges and requires a deeper level of domain expertise to make sense of it all. Because to answer questions about human health, we need human data science. 

To tap the potential and successfully ride the data science wave, healthcare companies need to start thinking differently about how data and technology play in a role in personalizing healthcare, conducting virtual trials, engaging patients directly via innovative digital platforms and applications of blockchain and AI in shaping the future of healthcare. 

Human Data Science is now the need of the hour as we transform and re-evaluate our approach in order to meet our commercial objectives and reduce disease burden.

Join us as at our complimentary one-day conference in Singapore on 11th Oct 2018: IQVIA 2018 APAC Healthcare Summit where Human Science meets Data Science.

Please write to us at to find out more!



9:00 – 9:10 

Welcome & introduction
Steven Harsono, Head of Public Health, Asia Pacific, IQVIA

9:10 – 9:30

Opening address 
Dr. Anand Tharmaratnam, President, Asia Pacific, IQVIA

9:30 – 10:00

Data Science: then & now
Data has become one of the most valuable assets in an organization and data science is the key to unlocking its latent potential. We explore data science’s journey in transforming the healthcare industry & look at what the future holds in the exciting area. 
Nawal Roy, Founder & Chief Executive Officer, Holmusk

10:00 – 10:30

The future of healthcare in Asia Pacific: what’s next?
With half the world’s population and the second largest Pharma market, Asia Pacific as a region is the most dynamic of the global economy and continues to rise in prominence. With increasing investment, innovation and digitization across industries, how do we see the future of healthcare evolving in Asia Pacific?  
Abrar Mir, Founder and Managing Partner, Quadria Capital

10:30 – 10:45 

Coffee break

10:45 – 11:15

Building consumers from patients: the Asia experience
As the Asia self-care market grows rapidly, how should Consumer Health companies build and adapt the ecosystem and services required to help the new informed consumer optimize their wellness goals? We deep-dive into ‘The Asia experience’ and take a look at what the Healthcare companies should be doing differently to delight the evidence-seeking fast-moving consumer health customer

Jude Uzonwanne, Principal, Consulting Group, Asia Pacific,  IQVIA
Carla Speering, Director of Marketing Self Care “New Growth Areas”, Asia Pacific, Johnson & Johnson
Peter Condron, Head of Data Science, Danone Precision Nutrition D-Lab
Stéphane Jacqmin, Head of Consumer Healthcare, South East Asia & China, Sanofi Consumer Healthcare

11:15 – 11:45

Generating meaningful and compliant real-world evidence in Asia
The evolution of healthcare and technology is providing significant opportunity to transform the way we generate data to understand disease. Complex and disparate data sets are now available in Asia Pacific, enabling the transformation of data generation methodologies. What are the challenges of generating meaningful data in a compliant and useful way? How does this impact better access and patient-centricity?

Dr. Ken Lee, Chief Medical Officer, Head, Medical & Scientific Solutions, Asia Pacific, IQVIA
Andy Barnett, Head of Commercial and Innovation, Asia Pacific, Roche
Dr. Jonathan Tan, Head of Patient Access, Asia Cluster, Novartis
Dr. Kenneth Sim, Regional Medical Advisor Cardiovascular, Bayer Pharmaceuticals
Kuldeep Singh Rajput, Founder and Chief Executive Officer, Biofourmis

11:45 – 12:15

Asia Pacific’s digital journey towards customer centricity
‘Customer centricity’ has moved from being a buzz-word to becoming a reality in how companies deploy healthcare strategies and operations. We discuss the role digital applications play in enabling and empowering healthcare companies to function as customer-centric organizations 

Jonathan Foster, Practice Leader, Technologies, Asia Pacific, IQVIA
Glenn Cross, Head of Commercial Execution, APMA, Novartis
John Cairns
, Head of Multi-Channel Engagement and Digital Innovation, Asia, Sanofi

12:15 – 13:15 

Networking lunch

Breakout Sessions:

Track 1: Virtual is the new reality

Track 2: Technology transforming healthcare

Track 3: China in Focus

13:15 – 13:45

Orchestrating virtual trials
Virtual (or direct to patient) trials are no longer the stuff of fiction. This session will examine how this innovative trial approach is transforming the clinical trial landscape driving step-change improvement in bringing new molecules to market.

Josh Rose, Vice President, Global Head of Strategy, R&D Solutions, IQVIA
Transforming integrated care through technology [Fireside chat]
The case has been made & proved for the need of patient access and support programs in Asia Pacific. We now explore how technology applications are required to connect the dots around data integration, patient experience, stakeholder engagement, in order to provide more effective and sustainable integrated care service for patients

Sol Magaz, Head of Consulting, Southeast Asia, IQVIA
Amkidit Afable, Director, Business Model Innovation, Johnson & Johnson
Farouk Meralli, Chief Executive Officer, mClinica
Prof.Dr. Jörg Kreuzer, Medical Director, ROPU SEASK, Boehringer Ingelheim

China: future shaping 
With its first home grown Oncology drug approved this year & with the world’s second largest pharma market China is undoubtedly a ‘mover and shaker’ of Asia and at the same time is seeing rapid change. How then do we crack the ‘China code’? We take a look at key trends and market drivers, regulatory updates and future outlook. We also explore the biopharma boom and its impact on the industry

Dr. Tong Guo, Vice President & Head of Business Development, Greater China, IQVIA

13:45 – 14:15

AI for You and I 
The hype around AI shows no signs of slowing down and its potential to transform healthcare delivery is limitless. But what are some of the challenges in application and how can we make the most of the opportunities?  

Sengmeng Koo, Head, Alliances and Partnerships, AI Singapore
Improving public health outcomes via data science
Data science has made it possible to draw connections across the entire disease continuum, making it possible for us to better understand population health. We take a look at how digital can be used to prevent, diagnose and implement public health initiatives for alleviating the global disease burden.

Steven Harsono, Head of Public Health, Asia Pacific, IQVIA
Jonathan Stambolis, Founder &  Chief Executive Officer, Zenysis Technologies 
Prof. Marcus Ong, Head, Health Services Research Center (HSRC), SingHealth
Nicolas Boillot, Chief Operating Officer, SystemOne
Functional service provision in China 
In an environment of rapid growth and change, the biopharma industry faces challenges to keep pace with human capital needs for clinical trial execution. China’s unique needs, in combination with ever-present financial pressures, dictate robust resource management mechanisms. In this session we’ll dive deeper into the tenets of a functional service partnership and what makes FSP a good bet in China.

Jovan Willford, Vice President, Clinical FSP, IQVIA

14:15 – 14:25

Break to change rooms

14:25 – 15:00

Compliance in a digital world
While the rise of digital increases overall connectivity, efficiency and transparency, it also presents companies with the challenge of ensuring compliance in a digital world. We investigate the need for increased compliance and the tools and processes to achieve this.

Hywel Evans, Director, Analytics Centre of Excellence, Asia Pacific, IQVIA
John Cairns, Head of Multi-Channel Engagement and
Dr. Sushrut Bhatt
, Director, Medical Governance, Quality & Risk Management, GSK
Tony Estrella, Managing Director – Health, Taliossa Digital Innovation, Asia, Sanofi
Use of innovative technology: direct-to-patient
In an increasingly connected world, with increasingly informed patients, the need for healthcare stakeholders to engage patients directly has become a necessity. We discuss the perspectives and innovative approaches of different healthcare stakeholders on direct-to-patient engagement.

David Hou, Head of MedTech, Asia Pacific, IQVIA
Enver Erkan, Country Manager, Singapore, Pfizer
Josh Rose, Vice President, Global Head of Strategy, R&D Solutions, IQVIA
Dr. Snehal Patel, Chief Executive Officer & Co-Founder, MyDoc
Dr. Steven Tucker, Founder, Tucker Medical Chief Medical Officer, CXA Group

Rise of the virtual rep
China, like several countries in Asia, faces challenges related to long distances, compliance, remote access & infrastructure, making accessibility a concern. However, the technology boom in Asia has ensured that innovative tech solutions are overcoming these barriers. We unveil the latest in ‘virtual reps’ technology to ensure effective and efficient HCP engagements. 

Dr. Kings Wang, Senior Director, Strategic Planning & Business Development, Head of Contract Sales & Medical Service, Greater China, IQVIA

15:00 – 15:30

Coffee break

15:30 – 16:15

Asia Pacific c-suite roundtable | Biotech’s role in shaping the future of Asian healthcare 
Over the past decade, SEA has seen a rise in the number of innovative ‘home-grown’ biotech. What has led to their growth and success, what are some challenges they face and what to look out for while navigating the complex landscape? We speak to some of Asia Pacific’s top biotech CEOs to hear their views on how biotech will shape the future of Asian Healthcare

Bhavani Sivalingam, Senior Vice President, R&D Solutions, Asia Pacific, IQVIA
Dr. Anil Ratty, Chairman &  Chief Executive Officer, Cennerv Pharma
Dr. Carl Firth, Chief Executive Officer, Aslan Pharmaceuticals
Dr. Charles Stacey, President & Chief Executive Officer, Cerecin.

16:15 – 16:55

Personalized medicine: Human Data Science at its best [Keynote panel]
Personalized medicine is the frontier of healthcare and we have begun making inroads. In our keynote panel, we explore how data science applications are being used to further genetic profiling, targeted therapies, pharmacogenomics and more, in finally delivering personalized healthcare to individual patients 

Dr. Senthil Sockalingam, Vice President, Head of Real World Insights, Asia Pacific, IQVIA
Colin Albert, Chief Executive Officer, genomiQa
Danny Yeung, Chief Executive Officer, Prenetics
Nawal Roy, Founder & Chief Executive Officer, Holmusk

Richard Batchelder, Commercial Director for Personalized Health, Market Development, Roche

16:55 – 17:00

Closing address 
Nitin Goel, Vice President and General Manager, Southeast Asia, IQVIA 

17:00 – 18:00

Networking drinks


IQVIA 2017 APAC Healthcare Summit Event highlight